Abstract:Introduction: Mitochondria are essential for generating cellular energy and are significant in the pathogenesis of obesity. Peptide PDBSN has been demonstrated to inhibit the adipogenic differentiation of adipocytes in vitro and improves metabolic homoeostasis in vivo. Therefore, in this study, we further investigated the effects of PDBSN on the morphology, synthesis, and function of adipocyte mitochondria. Methods: Human visceral and subcutaneous primary preadipocytes (HPA-v and HPA-s) were cultured into mature adipocytes. Intracellular triglyceride content was assessed using oil-red O staining and tissue triglyceride determination. Gene and protein levels associated with mitochondrial synthesis were detected using real-time quantitative polymerase chain reaction and western blotting. Mitochondrial membrane potentials and ROS were detected using fluorescent indicators. Morphological changes were observed by electron microscopy. Results: PDBSN significantly increased mitochondrial membrane potential (MMP), while decreasing intracellular triglyceride (TG) and intracellular reactive oxygen species (ROS) levels. On the other hand, the transcription and protein levels of genetic marker genes PGC1-α and MTFA were significantly up-regulated after PDBSN administration. Further studies showed that transcriptional and protein levels of mitochondrial fusion and fission genetic markers MFN1, MFN2, NRF1, and DRP1 increased. Conclusion: PDBSN significantly reduces intracellular TG and ROS levels and increases MMP. The maximum respiratory capacity in adults significantly increases after PDBSN administration, and ROS levels are significantly reduced. This suggests that PDBSN improves mitochondrial function to some extent, which not only provides an essential basis for the pathophysiology of obesity but also provides insights for the development of new drugs to treat obesity and metabolic diseases.

A Novel Peptide Suppresses Adipogenic Differentiation Through Activation of the AMPK Pathway.

Bioactive peptides PDBSN improve mitochondrial function and suppression the oxidative stress in human adiposity cells

Liposome-encapsulated Peptide PDBSN Ameliorates High-Fat-diet-induced Obesity and Improves Metabolism Homeostasis

Adiponectin Receptor Agonist AdipoRon Suppresses Adipogenesis in C3H10T1/2 Cells Through the Adenosine Monophosphate-Activated Protein Kinase Signaling Pathway

Human milk derived peptide AOPDM1 attenuates obesity by restricting adipogenic differentiation through MAPK signalling

Targeting Adenosine Receptor by Polydeoxyribonucleotide: An Effective Therapeutic Strategy to Induce White-to-Brown Adipose Differentiation and to Curb Obesity

A Novel Peptide RIFV Suppresses Human Adipocyte Differentiation Through the Inhibition of C/EBP-β Expression

Antidiabetic features of AdipoAI, a novel AdipoR agonist

Molecular Mechanisms of Adipogenesis: The Anti-adipogenic Role of AMP-Activated Protein Kinase

Shp2 Suppresses the Adipogenic Differentiation of Preadipocyte 3T3-L1 Cells at an Early Stage

Promotion of Adiponectin Multimerization by Emodin: A Novel AMPK Activator with PPARγ‐agonist Activity

Obesity-related metabolic disorders mitigated by peptides designed to modulate adiponectin assembly.

Sampsonione F suppresses adipogenesis via activating p53 pathway during the mitotic clonal expansion progression of adipocyte differentiation

WSF-P-1, a Novel AMPK Activator, Promotes Adiponectin Multimerization in 3T3-L1 Adipocytes

Novel Small-Molecule Ampk Activator Orally Exerts Beneficial Effects on Diabetic Db/Db Mice

Profiling Analysis Reveals the Potential Contribution of Peptides to Human Adipocyte Differentiation.

A Novel Mix of Polyphenols and Micronutrients Reduces Adipogenesis and Promotes White Adipose Tissue Browning via UCP1 Expression and AMPK Activation

Identification of Dacinostat As a Potential Anti-Obesity Compound Through Transcriptional Activation of Adipose Thermogenesis in Mice

A protein kinase C α and β inhibitor blunts hyperphagia to halt renal function decline and reduces adiposity in a rat model of obesity-driven type 2 diabetes

A novel peptide protects against diet-induced obesity by suppressing appetite and modulating the gut microbiota

Adiponectin Prevents Reduction of Lipid-Induced Mitochondrial Biogenesis Via Ampk/Acc2 Pathway in Chicken Adipocyte